CGRP receptor antagonists

Details for Australian Patent Application No. 2005299852 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Deng, James Z.; Nguyen, Diem N.; Paone, Daniel V.; Burgey, Christopher S.

Agent Spruson & Ferguson

Pub. Number AU-B-2005299852

PCT Pub. Number WO2006/047196

Priority 60/621,111 22.10.04 US

Filing date 18 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 4 August 2011

International Classifications

C07D 403/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

26 April 2007 PCT application entered the National Phase

  PCT publication WO2006/047196 Priority application(s): WO2006/047196

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 August 2011 Application Accepted

  Published as AU-B-2005299852

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299862-Engine power assembly

2005299851-2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists